UNSPSC 51352103: Zearalenone or zeranol

This classification denotes a non-steroidal estrogen with the molecular formula C18H26O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 76LO2L2V39, chemically known as 1h-2-benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl- but generally known as zeranol, which bears US NIH Compound Identifier 22283. European Medicines Agency schedules Zeranol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00148MIG.

UNSPSC 51352103 Zearalenone or zeranol is a Commodity code that encompasses pharmaceutical active ingredients and compounds used in veterinary and human medicines. State and local governments procure these substances primarily through cooperative purchasing alliances that aggregate demand across multiple jurisdictions for cost efficiency and standardized supply chain management. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a principal issuing body under this code, sourcing generic pharmaceuticals and active pharmaceutical ingredients through multi-award contracts that serve participating state facilities and subordinate local government entities across multiple states, including Oregon.

MMCAP issued an RFP (Solicitation S1070000015802) on January 20, 2026, due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers: AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. The procurement evaluates vendors on fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), acceptance of a 3 percent administrative fee (5 percent), and price competitiveness (75 percent). Vendors must certify cGMP and Drug Supply Chain Security Act compliance, maintain relationships with at least two of three authorized wholesalers, and carry commercial general liability insurance of $5 million per occurrence. Products must have FDA approval and at least a one-year expiration date from manufacture with six-month minimum shelf life. The contract term is two years for new vendors with optional extensions, or alignment with existing expiration dates through June 30, 2028 for incumbents. No award value or budget range is disclosed in solicitation materials; vendors should anticipate performance penalties of $200 to $1,500 per violation for late reporting, missed onboarding, or improper class-of-trade denials.